O’Neill Institute Fall Conversation Series with Gordon Schatz
Innovation and Health Law:
Comparing a Chinese and U.S. Regulation on Medical Device Innovation
Gordon B. Schatz, Esq.
China Life Science Integration Partner
Reed Smith LLP
Innovation and health law is a new and evolving area of health care policy. The China Food and Drug Administration is promulgating a regulation to fast track approval of innovative medical devices. This conversation session will compare China’s pending regulation with similar regulations in the United States. This session will also invite attendees to discuss how regulations can advance domestic and global health care innovation that improve net health outcomes. Since 2009, Gordon Schatz has been working in Reed Smith’s Asia offices to help introduce innovative medical devices and drugs into China. Gordon represents device and drug manufacturers in the United States before the Centers for Medicare and Medicaid Services to obtain Medicare coverage, codes and payment for innovative health care products. He has secured improved reimbursement for specialized cardiac implants, orphan ophthalmology drugs, nuclear medicine imaging procedures, minimally invasive orthopedic procedures, and other emerging health care products and services. Prior to his work at Reed Smith, Gordon served in the Massachusetts Department of Public Health – Certificate of Need Program, as an assistant administrator in a free-standing surgical center, and in a national health maintenance organization. A graduate from Haverford College with honors in history, Gordon received his JD from Temple University Law School with the Barrister’s Award for Excellence in Trial Advocacy. He has lectured at the Tsinghua Law School Health Law Research Center (Beijing) and has been recognized in Chambers USA (2007-2010) as one of America’s leading lawyers on health care reimbursement. He hikes, bikes and enjoys music. Gordon has co-directed Reed Smith’s 5K Charity Run.
The Fall Conversation Series is open to all Georgetown University.